Trade Mark Journal No.2026/034 21 August 2026

UK00004427437 7 August 2026 (5)

RAYZEBIO

International priority date claimed: 17 March 2026 (United States of America) (99707887)

Class 5: Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Diagnostic agents for medical purposes; Radio-isotope markers for therapeutic or diagnostic use; Pharmaceutical preparations for the treatment and prevention of cancer.

RayzeBio, Inc.

Representative: Sipara Limited